Key facts
- Notable investors include Particon.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for VitelleX
- ·The full record, as it builds
Funding rounds
No funding rounds for VitelleX are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VitelleX
Developer of a regenerative cell-manufacturing technology platform designed to industrialize donor-independent human tissue production. The company applies principles of early human development to create controlled 3D multicellular systems that generate stable, expandable cell types for regenerative medicine, enabling healthcare and life sciences markets to access reliable, scalable cell and tissue production.
- Sector
- Healthcare
- HQ
- Maastricht, Netherlands
- Founded
- 2025
- Website
- vitellex.com/
- Ownership
- Privately Held (backing)
VitelleX doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VitelleX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VitelleX in its N-PORT filings yet. We sweep new filings monthly.